COVID-19: Triple Antiviral Therapy & IL-1 Inhibition
May 12, 2020
Background: Current management of COVID-19 focuses on supportive care as there are yet to be robust, data driven treatments. To date, there has barely been...
Marco Torres
Lopinavir-Ritonavir in Hospitalized Patients with Severe COVID-19
March 21, 2020
Background: Since the introduction of SARS-CoV-2 to the world in December 2019, there have been no medications approved or proven effective for the treatment of...